Literature DB >> 2555442

Use of anticontamination primers in the polymerase chain reaction for the detection of human papilloma virus genotypes in cervical scrapes and biopsies.

A J van den Brule1, E C Claas, M du Maine, W J Melchers, T Helmerhorst, W G Quint, J Lindeman, C J Meijer, J M Walboomers.   

Abstract

A reliable application of the polymerase chain reaction (PCR) for detection of the human papilloma virus (HPV) genotypes in cervical smears and biopsies was developed. Primers flanking the HPV cloning site were used to avoid detection of cloned HPV plasmids. These anticontamination primers were used for the specific detection of HPV 6, 11, 16, 18, and 33 in cervical scrapes that had been tested previously for HPV with a combined modified filter in situ hybridization (modified FISH) and dot blotting procedure. The PCR appeared to be superior. Two groups of women were screened for HPV genotypes. Group A consisted of women belonging to a regularly screened population, and group B contained women attending a gynaecological clinic. It appeared that the overall prevalence of HPV in cytologically normal scrapes in the first group was 6%, whereas in the second group 12% was found. In scrapes with cytological dysplasia, the prevalence of HPV in group A and B was approximately 40% and 60%, respectively. HPV 16 was present predominantly. In biopsies of squamous cell carcinomas of the cervix uteri, an HPV prevalence rate of 90% was found, all of which contained only HPV 16 and 18. These data indicate an important role for HPV detection in the screening of cervical scrapes to identify women with an increased risk of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555442     DOI: 10.1002/jmv.1890290105

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  35 in total

1.  Detection of transforming gene regions of human papillomavirus type 16 in cervical dysplasias by the polymerase chain reaction.

Authors:  J Czeglédy; M Evander; L Veres; L Gergely; G Wadell
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

2.  Human papillomavirus and pterygium. Is the virus a risk factor?

Authors:  Nicolai Christian Sjö; Christian von Buchwald; Jan Ulrik Prause; Bodil Norrild; Troels Vinding; Steffen Heegaard
Journal:  Br J Ophthalmol       Date:  2006-12-19       Impact factor: 4.638

3.  Genital papillomaviruses, polymerase chain reaction and cervical cancer.

Authors:  M Stanley
Journal:  Genitourin Med       Date:  1990-12

4.  Rapid viral diagnosis.

Authors:  J M Best; S O'Shea; J Cason
Journal:  BMJ       Date:  1990-07-28

Review 5.  Use of the polymerase chain reaction to study the relationship between human papillomavirus infections and cervical cancer.

Authors:  W J Melchers; H C Claas; W G Quint
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-09       Impact factor: 3.267

6.  Analysis of transforming gene regions of human papillomavirus type 16 in normal cervical smears.

Authors:  J Czeglédy; I Batár; M Evander; L Gergely; G Wadell
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

7.  Oligonucleotide primers for DNA amplification of the early regions 1, 6, and 7 from human papillomavirus types 6, 11, 16, 18, 31, and 33.

Authors:  M Evander; E Bodén; L Bjersing; E Rylander; G Wadell
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

8.  Detection and typing of human papillomavirus by e6 nested multiplex PCR.

Authors:  K Sotlar; D Diemer; A Dethleffs; Y Hack; A Stubner; N Vollmer; S Menton; M Menton; K Dietz; D Wallwiener; R Kandolf; B Bültmann
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

9.  The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein.

Authors:  M Conrad; V J Bubb; R Schlegel
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

10.  Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses.

Authors:  B Kleter; L J van Doorn; J ter Schegget; L Schrauwen; K van Krimpen; M Burger; B ter Harmsel; W Quint
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.